Inovio Pharmaceuticals Inc vs Samsara Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Samsara Inc trades at $40.04 (market cap $23.49B). The key difference: Samsara Inc is far larger — about 299× Inovio Pharmaceuticals Inc's market cap, and Samsara Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | IOT | |
|---|---|---|
Market Cap | $78.55M | $23.49B |
Sector | Health | Technology |
52-Week High | $2.87 | $45.22 |
52-Week Low | $0.66 | $24.25 |
Enterprise Value | $49.56M | $22.76B |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →